Search

Search Constraints

You searched for: Author/Creator Opheim, Arild

Search Results

1. Adapting treatment length to opioid‐dependent individuals' needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone. (20th January 2021)

2. Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX). Issue 1 (December 2016)

3. Effectiveness, safety and feasibility of extended‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial. (22nd June 2018)

6. No increased pain among opioid‐dependent individuals treated with extended‐release naltrexone or buprenorphine‐naloxone: A 3‐month randomized study and 9‐month open‐treatment follow‐up study. Issue 2 (31st January 2019)

7. Optimal prevention of relapse among opioid users: A 12-week randomized controlled trial of extended-release naltrexone injections versus daily buprenorphine-naloxone. (1st February 2017)

8. Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial. Issue 5 (6th September 2021)